Repros Therapeutics, Inc. (RPRX)

[docbanker]

My recollection of the Vasomax disaster (and I was in med school at the time so it might be sketchy) was:
i) they got a partnership with was it glaxo?
ii) they had excess cash and started buying back stock (and buying it back as the short interest increased thus in effect buying from shorts)
iii) the carc studies came back and one rat had a brown fat tumor and the FDA shut down the whole thing

Not sure how this is more/(less) deceptive than any other company who has had a drug fail for efficacy/safety.

JP did what he thought was best in terms of running studies, using excess cash to reduce float b/c it was a good investment at the time and tried to not build an empire.